吉帕潘虹,罗一青

近视已成为一项全球性的公共卫生挑战，其高发性、低龄化趋势及高度近视比例的上升使得有效的干预手段成为防控关键。光学、药物及手术等治疗手段为近视管理提供了多种选择。脉络膜作为视网膜与巩膜间的血管组织，在近视进展中发挥关键调控作用，其厚度与血流等参数是评估干预效果与监测病情进展的重要生物标志。随着影像学技术的发展，近视干预措施对脉络膜结构及血流的动态影响已可实现无创、精准量化。本综述系统分析了不同治疗手段对脉络膜参数的影响效果，为个性化近视防控手段的制定提供理论依据。

近视干预；脉络膜厚度；脉络膜血流

[1] HOLDEN B A,FRICKE T R,WILSON D A,et al.Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050[J].Ophthalmology,2016,123(5):1036-1042. [2] 高振珊,陶芳标.多基因风险评分在儿童青少年近视早期预测研究中的应用[J].中国学校卫生,2024,45(1):148-152. [3] HWANG S,KONG M,SONG Y M,et al.Choroidal spatial distribution indexes as novel parameters for topographic features of the choroid[J].Sci Rep,2020,10(1):574. [4] SANKARIDURG P,BERNTSEN D A,BULLIMORE M A,et al.IMI 2023 Digest[J].Invest Ophthalmol Vis Sci,2023,64(6):7. [5] 黄晴予,武志峰.脉络膜结构与功能的研究进展[J].临床眼科杂志,2023,31(01):83-86. [6] LEE S S Y,LINGHAM G,ALONSO-CANEIRO D,et al.Choroidal Thickness in Young Adults and its Association with Visual Acuity[J].Am J Ophthalmol,2020,214:40-51. [7] AL-SHEIKH M,PHASUKKIJWATANA N,DOLZ-MARCO R,et al.Quantitative OCT Angiography of the Retinal Microvasculature and the Choriocapillaris in Myopic Eyes[J].Invest Ophthalmol Vis Sci,2017,58(4):2063-2069. [8] SPAIDE R F,KLANCNIK J M,JR.,COONEY M J.Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography[J].JAMA Ophthalmol,2015,133(1):45-50. [9] 徐旭东.光学相干断层扫描血管成像在眼科的临床应用现状研究[J].生命科学仪器,2025,23(04):9-11. [10] 赵雨暄,杨必,李晓莹,et al.高非球微透镜框架眼镜联合0.01%阿托品滴眼液的近视控制效果分析[J].四川大学学报(医学版),2024,55(05):1280-1287. [11] YAM J C,JIANG Y,TANG S M,et al.Low-Concentration Atropine for Myopia Progression(LAMP)Study:A Randomized,Double- Blinded,Placebo-Controlled Trial of 0.05%,0.025%,and 0.01%Atropine Eye Drops in Myopia Control[J].Ophthalmology,2019,126(1):113-124. [12] 李松玉,杨迎新,杨潮,et al.不同浓度阿托品滴眼液控制儿童青少年近视进展的Meta分析[J].国际眼科杂志,2023,23(01):96-102. [13] 谢小燕.青少年近视防控中低浓度阿托品的应用进展[J].临床合理用药,2025,18(20):177-180. [14] 尹连荣,张月强,高雅晴,et al.益精通络方抑制离焦型近视豚鼠近视进展的疗效及机制研究[J].中国中医眼科杂志,2021, 31(05):316-320+325. [15] 庞亚铮,王凯,于娟.“四明穴”为主小儿推拿干预轻中度近视的临床疗效研究[J].世界科学技术-中医药现代化,2023, 25(06):2196-2202. [16] 曲宸颍.基于OCT/OCTA技术开展经皮穴位电刺激干预大学生近视的疗效评价研究[D];山东中医药大学,2022. [17] WU H,PENG T,ZHOU W,et al.Choroidal vasculature act as predictive biomarkers of long-term ocular elongation in myopic children treated with orthokeratology:a prospective cohort study[J].Eye Vis(Lond),2023,10(1):27. [18] GONZáLEZ-MéIJOME J M,FARIA-RIBEIRO M A,LOPES-FERREIRA D P,et al.Changes in Peripheral Refractive Profile after Orthokeratology for Different Degrees of Myopia[J].Curr Eye Res,2016,41(2):199-207. [19] 陈乐民,刘思文,曹金芳,et al.近视青少年角膜塑形术后视网膜脉络膜血流变化研究[J].海南医学,2025,36(16):2365-2371. [20] ZHENG N N,TAN K W.The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia:A meta-analysis[J].Ophthalmic Physiol Opt,2022,42(6):1214-1226. [21] CHIANG S T,PHILLIPS J R,BACKHOUSE S.Effect of retinal image defocus on the thickness of the human choroid[J].Ophthalmic Physiol Opt,2015,35(4):405-413. [22] 何坤,潘冰心,杨苏云,et al.点扩散光学技术镜片在近视控制领域的研究进展[J].国际眼科杂志,2025,25(09):1476-1483. [23] LAM C S,TANG W C,TSE D Y,et al.Defocus Incorporated Soft Contact(DISC)lens slows myopia progression in Hong Kong Chinese schoolchildren:a 2-year randomised clinical trial[J].Br J Ophthalmol,2014,98(1):40-45. [24] LAM C S Y,TANG W C,TSE D Y,et al.Defocus Incorporated Multiple Segments(DIMS)spectacle lenses slow myopia progression:a 2-year randomised clinical trial[J].Br J Ophthalmol,2020,104(3):363-368. [25] XIANG K,WANG J,ZHU Z,et al.Changes in choroidal thickness in pre-myopic children after repeated low-level red-light therapy and their role in predicting myopia prevention and controlling myopic shift[J].Asia Pac J Ophthalmol(Phila),2025,14(2):100115. [26] XIONG R,ZHU Z,JIANG Y,et al.Sustained and rebound effect of repeated low-level red-light therapy on myopia control:A 2-year post-trial follow-up study[J].Clin Exp Ophthalmol,2022,50(9):1013-1024. [27] HU X,ZHOU L,WANG H,et al.The Value of Photo Biological Regulation Based on Nano Semiconductor Laser Technology in the Treatment of Hypertension Fundus Disease[J].J Nanosci Nanotechnol,2021,21(2):1323-1330. [28] HUANG F,SHU Z,HUANG Q,et al.Retinal Dopamine D2 Receptors Participate in the Development of Myopia in Mice[J].Invest Ophthalmol Vis Sci,2022,63(1):24. [29] 党宽荣,吴桐,杜红俊.后巩膜加固术临床应用的研究进展[J].国际眼科杂志,2021,21(05):832-835. [30] 刘维锋,刘莉莉,朱璇,et al.超高度近视患者后巩膜加固术后眼底形态的变化[J].眼科新进展,2023,43(07):558-561. [31] 许军,彭程,杨德琪,et al.后巩膜加固术对病理性近视球后血管血流动力学及脉络膜厚度的影响[J].中华眼视光学与视觉科学杂志,2016,18(5):264-268. [32] ZHANG Z,QI Y,WEI W,et al.Investigation of Macular Choroidal Thickness and Blood Flow Change by Optical Coherence Tomography Angiography After Posterior Scleral Reinforcement[J].Front Med(Lausanne),2021,8:658259. [33] LIU S,ZHANG X,NIU L,et al.Comparison of the Functional Optical Zone in Eyes With High Myopia With High Astigmatism After SMILE and FS-LASIK[J].J Refract Surg,2022,38(9):595-601. [34] FU D,LI M,KNORZ M C,et al.Intraocular pressure changes and corneal biomechanics after hyperopic small-incision lenticule extraction[J].BMC Ophthalmol,2020,20(1):129. [35] 肖秀梅.SMILE术后脉络膜厚度及脉络膜血管指数变化的临床研究[D],2024. [36] 杨士睿,钱甜甜,张静,et al.SMILE与FS-LASIK对近视患者脉络膜厚度的影响;proceedings of the 2023第二十二届国际眼科学学术会议､2023第二十二届国际视光学学术会议､2023第九届国际角膜塑形学术论坛､中国研究型医院学会眼科学与视觉科学专业委员会2023年学术年会､2022(第二十二届)上海国际眼科和视光技术及设备展览会､2022中国民营眼科医院和视光诊治中心展示推广会,中国上海,F,2023[C]. [37] CHEN X,WANG X,XU Y,et al.Five-year outcomes of EVO implantable collamer lens implantation for the correction of high myopia and super high myopia[J].Eye Vis(Lond),2021,8(1):40. [38] 徐英男,姚进,龙潭,et al.OCTA观察高度近视眼ICL植入术后视网膜血流密度的变化[J].中华眼视光学与视觉科学杂志, 2021,23(12):881-886. [39] ZHU Q J,WANG M Y,YU P,et al.Analysis of macular microvasculature and thickness after ICL implantation in patients with myopia using optical coherence tomography[J].Int J Ophthalmol,2020,13(12):1948-1954.

点击下载PDF